Saturday, July 11, 2026

Drug profile · INN

fesoterodine

fesoterodine (TOVIAZ) is a muscarinic acetylcholine receptor m2 antagonist.

EMA: approved Genito-urinary system and sex hormones (G04) G04BD11
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — fesoterodine
Class
Genito-urinary system and sex hormones (G04)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

fesoterodine (TOVIAZ) is a muscarinic acetylcholine receptor m2 antagonist.

Key facts

INN fesoterodine
Brand TOVIAZ
Mechanism Muscarinic acetylcholine receptor M2 antagonist
Therapeutic class Genito-urinary system and sex hormones (G04)
ATC code G04BD11

Mechanism of action

Muscarinic acetylcholine receptor M2 antagonist

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. apomorphine Genito-urinary system and sex hormones (G04)
  2. mirabegron Genito-urinary system and sex hormones (G04)
  3. oxybutynin Genito-urinary system and sex hormones (G04)
  4. raloxifene Genito-urinary system and sex hormones (G03)
  5. sildenafil Genito-urinary system and sex hormones (G04)
  6. silodosin Genito-urinary system and sex hormones (G04)

Frequently asked questions

What is fesoterodine?

fesoterodine (TOVIAZ) is a muscarinic acetylcholine receptor m2 antagonist.

What is the brand name for fesoterodine?

TOVIAZ is a marketed brand name for fesoterodine. Check FDA Drugs@FDA for the current US label holder and prescribing information.